| Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19 CT Bramante, JD Huling, CJ Tignanelli, JB Buse, DM Liebovitz, ... New England Journal of Medicine 387 (7), 599-610, 2022 | 197 | 2022 |
| Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial CT Bramante, JB Buse, DM Liebovitz, JM Nicklas, MA Puskarich, K Cohen, ... The Lancet Infectious Diseases 23 (10), 1119-1129, 2023 | 86 | 2023 |
| Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles ER Lusczek, NE Ingraham, BS Karam, J Proper, L Siegel, ES Helgeson, ... PloS one 16 (3), e0248956, 2021 | 60 | 2021 |
| Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up CT Bramante, JB Buse, D Liebovitz, J Nicklas, MA Puskarich, K Cohen, ... medRxiv, 2022 | 27 | 2022 |
| Vaccination against SARS-CoV-2 is associated with a lower viral load and likelihood of systemic symptoms CT Bramante, JL Proper, DR Boulware, AB Karger, T Murray, V Rao, ... Open forum infectious diseases 9 (5), ofac066, 2022 | 22 | 2022 |
| Morbidity and mortality trends of pancreatitis: an observational study NE Ingraham, S King, J Proper, L Siegel, EJ Zolfaghari, TA Murray, ... Surgical infections 22 (10), 1021-1030, 2021 | 15 | 2021 |
| Metabolite profiles associated with disease progression in influenza infection CH Wendt, S Castro-Pearson, J Proper, S Pett, TJ Griffin, V Kan, ... PloS one 16 (4), e0247493, 2021 | 12 | 2021 |
| Outpatient treatment of COVID-19 and the development of long COVID Over 10 Months: A multi-center, quadruple-blind, parallel group randomized phase 3 trial C Bramante, JB Buse, D Liebovitz, J Nicklas, M Puskarich, KR Cohen, ... | 10 | 2023 |
| Sigh ventilation in patients with trauma: the SiVent randomized clinical trial RK Albert, GJ Jurkovich, J Connett, ES Helgeson, A Keniston, H Voelker, ... JAMA 330 (20), 1982-1990, 2023 | 6 | 2023 |
| Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial DR Boulware, TA Murray, JL Proper, CJ Tignanelli, JB Buse, DM Liebovitz, ... Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022 | 5 | 2022 |
| Impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and booster on coronavirus disease 2019 (COVID-19) symptom severity over time in the COVID … DR Boulware, TA Murray, JL Proper, CJ Tignanelli, JB Buse, DM Liebovitz, ... Clinical Infectious Diseases 76 (3), e1-e9, 2023 | 3 | 2023 |
| Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes J Proper, J Connett, T Murray Clinical Trials 18 (4), 417-426, 2021 | 2 | 2021 |
| Network meta analysis to predict the efficacy of an approved treatment in a new indication JL Proper, H Chu, P Prajapati, MD Sonksen, TA Murray Research Synthesis Methods 15 (2), 242-256, 2024 | | 2024 |
| Acute Appendicitis Treatment Strategies and Mortality Based on Critical Illness on Admission: An Observational Study S King, J Proper, LK Siegel, NE Ingraham, CJ Tignanelli, JG Chipman, ... Surgical Infections 25 (1), 56-62, 2024 | | 2024 |
| Predicting Probability of Success for Phase III Trials via Propensity-Score-Based External Data Borrowing JL Proper, V Bunn, B Hupf, J Lin Statistics in Biopharmaceutical Research, 1-13, 2024 | | 2024 |
| An alternative metric for evaluating the potential patient benefit of response-adaptive randomization procedures J Proper, TA Murray Biometrics 79 (2), 1433-1445, 2023 | | 2023 |
| Patient Outcomes and Unit Composition With Transition to a High-Intensity ICU Staffing Model: A Before-and-After Study JL Proper, DA Wacker, S Shaker, J Heisdorffer, RM Shaker, LT Shiue, ... Critical Care Explorations 5 (2), e0864, 2023 | | 2023 |
| Wacker et al, Who Conclude That Vitamin C Monotherapy Failed to Significantly Reduce Mortality in Septic Shock Patients: Beware of Potential Confounding Factors! Reply RA Reilkoff, J Proper, DA Wacker CRITICAL CARE MEDICINE 50 (6), E612-E613, 2022 | | 2022 |
| Bayesian Methods for Response-Adaptive Randomization and Drug Repurposing JL Proper University of Minnesota, 2022 | | 2022 |
| VACCINATION STATUS AND SYMPTOM BURDEN FOR OUTPATIENTS WITH COVID-19 INFECTION N Deng, RC Atwater, JL Proper, J Huling, C Bramante, JM Nicklas, ... Journal of General Internal Medicine, S171-S171, 2022 | | 2022 |
